Doral, FL, January 18, 2018 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC PINK: ETST) (“ETST” or, the “Company”), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device R&D, president Nickolas S. Tabraue commits to donating 50,000 of his personal shares to be the first contributor to Earth Science Foundation (the foundation) to help individuals in need by providing access to effective cannabinoids and future formulas developed by the Company.
Earth Science Foundation, mentioned earlier this month is being activated, currently in the process to be a 501 (c)(3) status and structured with key individuals to help those in need. The company is currently in discussion with medical practitioners, organizations, and schools to donate ETST’s popular and effective cannabinoid products. The Foundation’s goal is to help individuals suffering from cancer, epilepsy, autism, addiction, and chronic pain. ETST plans to include participating organizations in human trials, and will provide the benefits and supplies to them at cost following the conclusion of said studies. To help fund this, Earth Science Foundation will accept donations on Go Fund Me Page to help supply ETST’s products to those who are in need and unable to purchase for themselves.
Gabriel Aviles, ETST’s current Chief Sales Officer soon to be Chief Learning Officer, will help educate the organizations on the benefits of using cannabinoids and the studies he plans on conducting. The Company is finalizing preparations to launch the anti-opioid cannabinoid formula, and is already to structure a study on a cannabinoid formula to help with the symptoms of autism, given the abundant positive feedback the Company has received from individuals diagnosed with autism.
Mr. Aviles comments, “We are at the forefront of a new frontier in modern medicine. We have seen the tremendous potential with our formulas have to improve the health of our patients, and we want to formally research and share our results, and our life-changing treatments with as many people as we can. A lot of our ability to do this stems from education. I will do my best to educate students, teachers, parents, and the medical community on the benefits we have discovered in CBD-based treatments.”
Nickolas S. Tabraue, the Company’s president, director, and COO has agreed to donate his Q1 2018 compensation of 50,000 shares to the foundation. The shares will be used as an asset for the foundation as the Company continues to grow and require additional funds.
Mr. Tabraue concludes, “I have received a tremendous amount of positive feedback on all of our CBD based products from children, adults, and elderly patients suffering from cancer, epilepsy, chronic pain, and autism to name a few. Nothing feels greater than knowing that my company’s products have helped change lives in a positive way. I do know that there are many patients who are not able to purchase our products, and that they seek extra help in addition to the discounts we offer. I feel the foundation is our solution to truly help those in need, especially to make sure they can continue to find improved health. As mentioned earlier, I’m currently in talks with many great medical practitioners, schools, and organizations, and I plan on sharing updates as they progress.”
About Earth Science Tech, Inc. (ETST): Earth Science Tech has among the highest quality, purity, and full spectrum High Grade Hemp CBD (Cannabidiol) Oil on the market. Made using the superior supercritical CO2 liquid extraction, our CBD Oil is 100% natural and organic. Our research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrate that we are the top nutritional and dietary supplement brand for High Grade Hemp CBD Oil.
To learn more and to buy CBD Hemp Oil please visit: www.earthsciencetech.com
About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.
To learn more please visit: www.Earthsciencepharmaceutical.com
About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide.
To learn more please visit: www.Cannabisthera.com
About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioid, Inc. is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by its unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.
To learn more please visit: www.kannabidioidinc.com
SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Dave Demarest (305) 546-7640
Earth Science Tech, Inc. Nickolas S. Tabraue, P/D/COO (305) 615-2118